OrbiMed Advisors »

Nkarta shares owned by OrbiMed Advisors

Quarter-by-quarter ownership of Nkarta (NKTX) shares owned by OrbiMed Advisors from 13F filings

Historical chart of OrbiMed Advisors investment in Nkarta

Tip: Access up to 7 years of quarterly data

All positions including Nkarta held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nkarta by OrbiMed Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $8.6M 800k 10.81

More positions owned by OrbiMed Advisors

Sinovac Biotech SHS (SVA)
Eli Lilly & Co. (LLY)
Edgewise Therapeutics (EWTX)
Boston Scientific Corporation (BSX)
Intuitive Surgical Com New (ISRG)
Biogen Idec (BIIB)
Merck & Co (MRK)
Janux Therapeutics (JANX)
Enliven Therapeutics (ELVN)
Tenet Healthcare Corp Com New (THC)
BioMarin Pharmaceutical (BMRN)
Alpine Immune Sciences (ALPN)
Disc Medicine (IRON)
Stryker Corporation (SYK)
Silverback Therapeutics (SPRY)

View all positions for OrbiMed Advisors

Top funds holding Nkarta

RA Capital Management
Boxer Capital
Deerfield Management Company
Adage Capital Partners GP
Samsara BioCapital
NEA Management Company
Sr One Capital Management
Commodore Capital
BlackRock
EcoR1 Capital
Vanguard Group
T. Rowe Price Investment Management
Cormorant Asset Management
Superstring Capital Management
Daniel D. Thurber

View all funds holding Nkarta